H.R. 796 · 119th Congress
Second Chance for Moms Act
In committee
See what this could mean for your district
Save your district in Account to view district-specific context for this bill.
Bill details
Introduced: 1/28/2025
Current status: In committee
Introduced by: Mary E. Miller (R · IL-15)
Bill ID: 119hr796
Latest official action: Referred to the House Committee on Energy and Commerce.
Bill overview
A neutral overview based on official congressional sources.
Introduced in House
Second Chance for Moms Act of 2025 This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)
Source: BILLSUM · Summary date: 1/28/2025
Related votes
Roll calls that reference this bill in official data.
0 roll calls
No related roll calls found yet for this bill.
Primary sources
Official links to verify details. No interpretation.
About this data
Non-partisan by design
OurCongress presents public records without political endorsement, interpretation, or advocacy.
Official sources
Data is sourced from official government records, including Congress.gov, GovInfo, the Clerk of the House, and the U.S. Senate.
AI-generated text
Some explanatory sections may be generated from official summaries and metadata to improve readability. They are not official government language and should be verified against primary sources.